Identify your patient’s actionable lung cancer mutations
Guideline-recommended, blood-based mutation results within 72 hours.
Nearly 80% of patients currently do not have mutation results available at their initial oncology consult.
How do we change this paradigm with blood-based testing?
Source: Lim, C., et.al. 2015. Biomarker Testing and Time to Treatment Decision in Patients with Advanced Non-Small Cell Lung Cancer. Ann Oncol first published online April 28, 2015
BLOOD-BASED RESULTS WITHIN 72 HOURS EXPEDITE TIME TO TREATMENT IN AS
LITTLE AS 8 DAYS2 FROM DIAGNOSTIC BIOPSY.
Tissue-based Tumor Mutation Testing: Presentation to Treatment
GeneStrat Tumor Mutation Testing: Presentation to Treatment
Reference: 1. NCCN Guidelines 2. Bowling, et al. J Clin Oncol 36, 2018 (suppl; abstr e18519) 3. Hagemann, et al. Cancer. 2015;121:631-9. 4. Vidaver RM et al. J Oncol Pract 2016 Jun 3;12(6):e643-53
Accurate, actionable genomic results